Predictors of systemic lupus erythematosus

A case-control study

https://doi.org/10.53730/ijhs.v6nS10.13361

Authors

  • Sultonov I. I. Samarkand State Medical University, Samarkand, Uzbekistan
  • Xasanov F. Sh Samarkand State Medical University, Samarkand, Uzbekistan
  • Eshmuratov S. Samarkand State Medical University, Samarkand, Uzbekistan
  • Uralov R. Sh Samarkand State Medical University, Samarkand, Uzbekistan
  • Shukurova D. Samarkand State Medical University, Samarkand, Uzbekistan
  • Ziyadullayev Sh. X. Samarkand State Medical University, Samarkand, Uzbekistan

Keywords:

lupus, SLE, risk factors, smoking, alcohol, stress

Abstract

Systemic lupus erythematosus is a multisystem autoimmune disease characterized by multiorgan system damage. In total 72 cases and 142 matched controls were interviewed between 2008 and 2019. Clinical data for all cases were obtained from the central patients' database. Using a multivariate model, cases with a history of hypertension tended to have an increased risk of the development of SLE (OR 3.7, 95% CI 1.36-7.9). Also, cases were more likely to report angina pectoris compared to controls (OR 4.7, 95% CI 1.6-24). There was a statistically significant association between a family history of any autoimmune disease and an increased risk of SLE (OR 2.25, 95% CI 1.25-4.05). Those who consume >200 grams of alcohol per week had a significantly lower risk of SLE, while very few participants contributed to this evidence. While those who smoke 2 to 5 cigarette packs per week had 2.64 times increased risk of SLE compared to non-smokers (OR = 2.64, 95% CI 0.97-7.18), however, none of the results on this exposure was statistically significant.  SLE may be associated both with endogenous and exogenous factors. Additional well-designed studies are needed to explore a cause-and-effect relationship between endogenous and exogenous factors and SLE.lupus

Downloads

Download data is not yet available.

References

Ali, A., Sayyed, Z., Ameer, M. A., Arif, A. W., Kiran, F. N. U., Iftikhar, A., Iftikhar, W., Ahmad, M. Q., Malik, M. B., & Kumar, V. (2018). Systemic lupus erythematosus: An overview of the disease pathology and its management. Cureus, 10(9).

Barbhaiya, M., Tedeschi, S. K., Lu, B., Malspeis, S., Kreps, D., Sparks, J. A., Karlson, E. W., & Costenbader, K. H. (2018). Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts. Annals of the Rheumatic Diseases, 77(2), 196–202.

Choi, M. Y., Barber, M. R. W., Barber, C. E. H., Clarke, A. E., & Fritzler, M. J. (2016a). Preventing the development of SLE: Identifying risk factors and proposing pathways for clinical care. Lupus, 25(8), 838–849.

Ekblom-Kullberg, S., Kautiainen, H., Alha, P., Leirisalo-Repo, M., & Julkunen, H. (2013). Smoking and the risk of systemic lupus erythematosus. Clinical Rheumatology, 32(8), 1219–1222.

El Sherbiny, D. A., & El Shereif, R. (2020). Risk factors for cataracts in a cohort of Egyptian systemic lupus erythematosus patients. The Egyptian Rheumatologist, 42(2), 113–116.

Ghaussy, N. O., Sibbitt Jr, W. L., & Qualls, C. R. (2001). Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: A case-control study. J Rheumatol, 28(11), 2449–2453.

Holroyd, C. R., & Edwards, C. J. (2009). The effects of hormone replacement therapy on autoimmune disease: Rheumatoid arthritis and systemic lupus erythematosus. Climacteric, 12(5), 378–386.

Jung, J.-Y., Nam, J.-Y., Kim, H.-A., & Suh, C.-H. (2015). Elevated salivary alpha-amylase level, association between depression and disease activity, and stress as a predictor of disease flare in systemic lupus erythematosus: A prospective case–control study. Medicine, 94(30).

Lipsky, P. E. (2001). Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nature Immunology, 2(9), 764–766.

Moon, U. Y., Park, S. J., Oh, S. T., Kim, W.-U., Park, S.-H., Lee, S.-H., Cho, C.-S., Kim, H.-Y., Lee, W.-K., & Lee, S. K. (2004). Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood. Arthritis Res Ther, 6(4), 1–8.

Morales, E., Galindo, M., Trujillo, H., & Praga, M. (2021). Update on lupus nephritis: Looking for a new vision. Nephron, 145(1), 1–13.

Parisis, D., Bernier, C., Chasset, F., & Arnaud, L. (2019). Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity Reviews, 18(11), 102393.

Pollard, K. M., Christy, J. M., Cauvi, D. M., & Kono, D. H. (2018). Environmental xenobiotic exposure and autoimmunity. Current Opinion in Toxicology, 10, 15–22. https://doi.org/10.1016/j.cotox.2017.11.009

Ryan, M. J. (2009). The pathophysiology of hypertension in systemic lupus erythematosus. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 296(4), R1258-67.

Speyer, C. B., & Costenbader, K. H. (2018). Cigarette smoking and the pathogenesis of systemic lupus erythematosus. Expert Review of Clinical Immunology, 14(6), 481–487.

Published

12-10-2022

How to Cite

Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., & Ziyadullayev, S. X. (2022). Predictors of systemic lupus erythematosus: A case-control study. International Journal of Health Sciences, 6(S10), 175–182. https://doi.org/10.53730/ijhs.v6nS10.13361

Issue

Section

Peer Review Articles